Klin Onkol 1992; 5(4): 114.
Authors: Slávik Marek1992-08-15:New anticancer drugs under clinical evaluation by the national cancer institute
Authors: Slávik Marek1992-08-15:New anticancer drugs under clinical evaluation by the national cancer institute
Klin Onkol 1992; 5(4): 115-116.
Authors: Vítek Pavel, Andrýsek Oskar1992-08-15:Is Leucovorin (LV) really a true biologic response modifier (BRM) of fluorouracil (FU)?
Authors: Vítek Pavel, Andrýsek Oskar1992-08-15:Is Leucovorin (LV) really a true biologic response modifier (BRM) of fluorouracil (FU)?
Klin Onkol 1992; 5(4): 117-120.
Authors: Neuwirtová Radana, Cukrová Věra, Kvasnička Jan1992-08-15:Inhibitors of the cell growth
Authors: Neuwirtová Radana, Cukrová Věra, Kvasnička Jan1992-08-15:Inhibitors of the cell growth
Klin Onkol 1992; 5(4): 121-123.
Keywords: malignant melanoma, occupation
Authors: Kolcová V., Munzarová M.1992-08-15:Employment and malignant melanoma
Keywords: malignant melanoma, occupation
Authors: Kolcová V., Munzarová M.1992-08-15:Employment and malignant melanoma
Klin Onkol 1992; 5(4): 124.
Authors: Cetkovský Petr1992-08-15:Report of the 5th international conference on treatment of acute leukemia
Authors: Cetkovský Petr1992-08-15:Report of the 5th international conference on treatment of acute leukemia
Klin Onkol 1992; 5(4): 124-125.
Authors: Adam Zdeněk1992-08-15:Report of the conference on Navalbin
Authors: Adam Zdeněk1992-08-15:Report of the conference on Navalbin
Klin Onkol 1992; 5(4): 125-126.
Authors: Jassem Jacek1992-08-15:6th World conference on lung cancer
Authors: Jassem Jacek1992-08-15:6th World conference on lung cancer
Klin Onkol 1992; 5(4): 127-128.
1992-08-15:Information of medicaments and the concern Shering
1992-08-15:Information of medicaments and the concern Shering
Klin Onkol 1992; 5(4): 128.
1992-08-15:Information of medicaments
1992-08-15:Information of medicaments
Klin Onkol 1992; 5(3): 67-72.
Authors: Čoupek Petr, Adam Zdeněk1992-06-15:Therapy of the multiple myeloma
Authors: Čoupek Petr, Adam Zdeněk1992-06-15:Therapy of the multiple myeloma
Klin Onkol 1992; 5(3): 73-76.
Keywords: hemopoiesis, hemopoietic growth factors, interleukins, chemotherapy
Authors: Krahulcová E.1992-06-15:Haemopoetic growth factors — biology and the clinical use
Keywords: hemopoiesis, hemopoietic growth factors, interleukins, chemotherapy
Authors: Krahulcová E.1992-06-15:Haemopoetic growth factors — biology and the clinical use
Klin Onkol 1992; 5(3): 77-79.
Keywords: Apudoma, diagnosis, apudoma - postoperative monitoring, apudoma - therapy
Authors: Nekulová Miroslava, Dvořák Karel, Němec Jaroslav, Mechl Zdeněk, Chrenko Vojtěch1992-06-15:Apudomas in the contemporary clinical practice
Keywords: Apudoma, diagnosis, apudoma - postoperative monitoring, apudoma - therapy
Authors: Nekulová Miroslava, Dvořák Karel, Němec Jaroslav, Mechl Zdeněk, Chrenko Vojtěch1992-06-15:Apudomas in the contemporary clinical practice
Klin Onkol 1992; 5(3): 80-82.
Keywords: cisplatin-based chemotherapy, testicular cancer, adverse side effects, hypomagnesemia, Mg-supplementation
Authors: Ondruš Dalibor, Polakovičová D., Revúsová V.1992-06-15:Hypomagnesemia in patients with germinal testicular tumors treated by chemotherapy with cisplatin
Keywords: cisplatin-based chemotherapy, testicular cancer, adverse side effects, hypomagnesemia, Mg-supplementation
Authors: Ondruš Dalibor, Polakovičová D., Revúsová V.1992-06-15:Hypomagnesemia in patients with germinal testicular tumors treated by chemotherapy with cisplatin
Klin Onkol 1992; 5(3): 83-84.
Keywords: squamous cell, carcinoma, tumour markers, SCC-Antigen
Authors: Jabůrek L., Fingerová H.1992-06-15:SCC-Antigen - tumor marker of the squamous cell carcinoma
Keywords: squamous cell, carcinoma, tumour markers, SCC-Antigen
Authors: Jabůrek L., Fingerová H.1992-06-15:SCC-Antigen - tumor marker of the squamous cell carcinoma
Klin Onkol 1992; 5(3): 85-87.
Keywords: pharmacokinetic parameters, fazarabine, cirrhosis of the liver, drug dosing
Authors: Skálová Martina, Elis J., Trnavská Z.1992-06-15:Pharmacokinetics l-β-D-arabinofuranosyl-5-azacytosine in the model of rats with chronic mutilated liver
Keywords: pharmacokinetic parameters, fazarabine, cirrhosis of the liver, drug dosing
Authors: Skálová Martina, Elis J., Trnavská Z.1992-06-15:Pharmacokinetics l-β-D-arabinofuranosyl-5-azacytosine in the model of rats with chronic mutilated liver